View Item 

Show simple item record

Tackling overtreatment of prostate cancer
dc.contributor.authorBeebe-Dimmer, Jennifer L.en_US
dc.contributor.authorShahinian, Vahakn B.en_US
dc.date.accessioned2011-11-10T15:36:27Z
dc.date.available2012-12-03T21:17:30Zen_US
dc.date.issued2011-10-15en_US
dc.identifier.citationBeebe‐dimmer, Jennifer ; Shahinian, Vahakn (2011). "Tackling overtreatment of prostate cancer ." Cancer 117(20): 4576-4578. <http://hdl.handle.net/2027.42/87027>en_US
dc.identifier.issn0008-543Xen_US
dc.identifier.issn1097-0142en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/87027
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.titleTackling overtreatment of prostate canceren_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michiganen_US
dc.contributor.affiliationotherDepartment of Population Studies and Disparities Research, Karmanos Cancer Institute and Department of Oncology, Wayne State University, Detroit, Michiganen_US
dc.contributor.affiliationother110 E. Warren Avenue, Detroit, MI 48201; Fax: (313) 578‐4306en_US
dc.identifier.pmid21480202en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/87027/1/26106_ftp.pdf
dc.identifier.doi10.1002/cncr.26106en_US
dc.identifier.sourceCanceren_US
dc.identifier.citedreferenceBill‐Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2005; 352: 1977 ‐ 1984.en_US
dc.identifier.citedreferenceHolmberg L, Bill‐Axelson A, Helgesen F, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med. 2002; 347: 781 ‐ 789.en_US
dc.identifier.citedreferenceAlbertsen PC, Hanley JA, Fine J. 20‐year outcomes following conservative management of clinically localized prostate cancer. JAMA. 2005; 293: 2095 ‐ 2101.en_US
dc.identifier.citedreferenceDaskivich TJ, Chamie K, Kwan L, et al. Comorbidity and competing risks for mortality in men with prostate cancer. Cancer. 2011; 117: 4642 ‐ 4650.en_US
dc.identifier.citedreferenceD'Amico AV, Whittington R, Malkowicz SB, et al. Pretreatment nomogram for prostate‐specific antigen recurrence after radical prostatectomy or external‐beam radiation therapy for clinically localized prostate cancer. J Clin Oncol. 1999; 17: 168 ‐ 172.en_US
dc.identifier.citedreferenceAlbertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. The impact of co‐morbidity on life expectancy among men with localized prostate cancer. J Urol. 1996; 156: 127 ‐ 132.en_US
dc.identifier.citedreferenceKieszak SM, Flanders WD, Kosinski AS, Shipp CC, Karp H. A comparison of the Charlson comorbidity index derived from medical record data and administrative billing data. J Clin Epidemiol. 1999; 52: 137 ‐ 142.en_US
dc.identifier.citedreferenceWalz J, Gallina A, Saad F, et al. A nomogram predicting 10‐year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol. 2007; 25: 3576 ‐ 3581.en_US
dc.identifier.citedreferenceCowen ME, Halasyamani LK, Kattan MW. Predicting life expectancy in men with clinically localized prostate cancer. J Urol. 2006; 175: 99 ‐ 103.en_US
dc.identifier.citedreferenceThompson I, Thrasher JB, Aus G, et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol. 2007; 177: 2106 ‐ 2131.en_US
dc.identifier.citedreferenceMohler J, Bahnson RR, Boston B, et al. NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer. J Natl Compr Canc Netw. 2010; 8: 162 ‐ 200.en_US
dc.identifier.citedreferenceDaskivich TJ, Chamie K, Kwan L, et al. Overtreatment of men with low‐risk prostate cancer and significant comorbidity [published online ahead of print November 29, 2010]. Cancer. 2010.en_US
dc.identifier.citedreferenceCooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol. 2010; 28: 1117 ‐ 1123.en_US
dc.identifier.citedreferenceMiller DC, Gruber SB, Hollenbeck BK, Montie JE, Wei JT. Incidence of initial local therapy among men with lower‐risk prostate cancer in the United States. J Natl Cancer Inst. 2006; 98: 1134 ‐ 1141.en_US
dc.identifier.citedreferenceLevine GN, D'Amico AV, Berger P, et al. Androgen‐deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. Circulation. 2010; 121: 833 ‐ 840.en_US
dc.identifier.citedreferenceKrahn MD, Bremner KE, Asaria J, et al. The ten‐year rule revisited: accuracy of clinicians' estimates of life expectancy in patients with localized prostate cancer. Urology. 2002; 60: 258 ‐ 263.en_US
dc.identifier.citedreferenceWalz J, Gallina A, Perrotte P, et al. Clinicians are poor raters of life‐expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer. BJU Int. 2007; 100: 1254 ‐ 1258.en_US
dc.identifier.citedreferenceTewari A, Johnson CC, Divine G, et al. Long‐term survival probability in men with clinically localized prostate cancer: a case‐control, propensity modeling study stratified by race, age, treatment and comorbidities. J Urol. 2004; 171: 1513 ‐ 1519.en_US
dc.identifier.citedreferenceSchwartz LM, Woloshin S, Black WC, Welch HG. The role of numeracy in understanding the benefit of screening mammography. Ann Intern Med. 1997; 127: 966 ‐ 972.en_US
dc.identifier.citedreferenceLin GA, Aaronson DS, Knight SJ, Carroll PR, Dudley RA. Patient decision aids for prostate cancer treatment: a systematic review of the literature. CA Cancer J Clin. 2009; 59: 379 ‐ 390.en_US
dc.identifier.citedreferenceWalter LC, Bertenthal D, Lindquist K, Konety BR. PSA screening among elderly men with limited life expectancies. JAMA. 2006; 296: 2336 ‐ 2342.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
26106_ftp.pdf
Size:
74.30KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.